GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » EBITDA Margin %

PharmaRoth Labs (PharmaRoth Labs) EBITDA Margin % : -49.00% (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PharmaRoth Labs's EBITDA for the three months ended in Mar. 2011 was $-0.10 Mil. PharmaRoth Labs's Revenue for the three months ended in Mar. 2011 was $0.20 Mil. Therefore, PharmaRoth Labs's EBITDA margin for the quarter that ended in Mar. 2011 was -49.00%.


PharmaRoth Labs EBITDA Margin % Historical Data

The historical data trend for PharmaRoth Labs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs EBITDA Margin % Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
EBITDA Margin %
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -49.00

Competitive Comparison of PharmaRoth Labs's EBITDA Margin %

For the Biotechnology subindustry, PharmaRoth Labs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's EBITDA Margin % falls into.



PharmaRoth Labs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PharmaRoth Labs's EBITDA Margin % for the fiscal year that ended in Jun. 2010 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2010 )/Revenue (A: Jun. 2010 )
=-0.02/0
= %

PharmaRoth Labs's EBITDA Margin % for the quarter that ended in Mar. 2011 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2011 )/Revenue (Q: Mar. 2011 )
=-0.098/0.2
=-49.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PharmaRoth Labs EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines